Cancer Indicators - Yates County
2007-2009
| Indicator | Data Links | 3 Year Total | County Rate | NYS Rate | Sig.Dif. | NYS Rate exc NYC | Sig.Dif. | County Ranking Group |
|---|---|---|---|---|---|---|---|---|
| All cancers | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 443 | 602.0 | 536.5 | Yes | 599.7 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 443 | 487.1 | 489.6 | No | 520.0 | No | 1st |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 163 | 221.5 | 179.9 | Yes | 204.1 | No | 3rd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 163 | 176.0 | 163.0 | No | 173.9 | No | 2nd |
| Lip, Oral Cavity, and Pharynx Cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 6 | 8.2* | 11.5 | No | 12.7 | No | 1st |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 6 | 6.1* | 10.4 | No | 10.8 | No | 1st |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 2 | 2.7* | 2.3 | No | 2.4 | No | 3rd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 2 | 2.0* | 2.1 | No | 2.0 | No | 2nd |
| Colon and rectum cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 38 | 51.6 | 50.4 | No | 53.9 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 38 | 40.5 | 45.8 | No | 46.2 | No | 1st |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 11 | 14.9 | 17.4 | No | 18.5 | No | 1st |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 11 | 12.0 | 15.7 | No | 15.7 | No | 1st |
| Lung and bronchus cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 63 | 85.6 | 69.8 | No | 83.9 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 63 | 68.2 | 63.8 | No | 72.2 | No | 1st |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 39 | 53.0 | 46.9 | No | 57.2 | No | 2nd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 39 | 41.3 | 42.8 | No | 49.0 | No | 1st |
| Female breast cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 55 | 146.0 | 147.1 | No | 164.9 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 55 | 111.0 | 126.9 | No | 136.1 | No | 1st |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 13 | 34.5 | 26.7 | No | 28.8 | No | 4th |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 13 | 28.1 | 21.7 | No | 22.2 | No | 4th |
| Crude late stage incidence per 100,000 | (Table) (Trend) (Map) | 2 | 5.3* | 8.0 | No | 8.3 | No | 1st |
| Age-adjusted late stage incidence per 100,000 | (Table) (Trend) (Map) | 2 | 4.2* | 6.8 | No | 6.8 | No | 1st |
| Cervix uteri cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 2 | 5.3* | 8.9 | No | 7.9 | No | 1st |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 2 | 4.2* | 8.3 | No | 7.4 | No | 1st |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 0 | 0.0* | 2.7 | No | 2.2 | No | 1st |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 0 | 0.0* | 2.3 | No | 1.9 | No | 1st |
| Ovarian cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 5 | 13.3* | 15.2 | No | 16.5 | No | 1st |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 5 | 9.7* | 12.9 | No | 13.4 | No | 1st |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 7 | 18.6* | 9.6 | No | 11.0 | No | 4th |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 7 | 15.9* | 7.8 | No | 8.5 | No | 4th |
| Prostate cancer | ||||||||
| Crude incidence per 100,000 | (Table) (Trend) (Map) | 58 | 161.5 | 169.1 | No | 186.0 | No | 2nd |
| Age-adjusted incidence per 100,000 | (Table) (Trend) (Map) | 58 | 124.6 | 166.9 | Yes | 171.2 | Yes | 1st |
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 8 | 22.3* | 18.5 | No | 19.2 | No | 3rd |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 8 | 21.9* | 21.6 | No | 20.8 | No | 3rd |
| Crude late stage incidence per 100,000 | (Table) (Trend) (Map) | 3 | 8.4* | 6.7 | No | 6.6 | No | 3rd |
| Age-adjusted late stage incidence per 100,000 | (Table) (Trend) (Map) | 3 | 7.8* | 7.2 | No | 6.6 | No | 3rd |
| Melanoma cancer mortality | ||||||||
| Crude mortality rate per 100,000 | (Table) (Trend) (Map) | 1 | 1.4* | 2.3 | No | 3.1 | No | 1st |
| Age-adjusted mortality rate per 100,000 | (Table) (Trend) (Map) | 1 | 0.8* | 2.1 | No | 2.7 | No | 1st |
| Age-adjusted % of women 18 years and older with pap smear in past 3 years (2008-2009) | (Table) (Map) | N/A | 81.4 | 82.7 | No | 82.6 | No | 3nd |
| % of women 40 years and older with mammography screening in past 2 years (2008-2009) | (Table) (Map) | N/A | 80.7 | 79.7 | No | 81.9 | No | 2rd |
N/A: Data not available
*: Fewer than 10 events in the numerator, therefore the rate is unstable
